It reveals a closed relationship between mean_Hb and mean_HCT and CKD prognosis, and on the other hand, it suggests that levels of Hb and HCT may vary with the progression of the disease and the different treatments employed in patients with CKD stages 3–4. This evidence concerns the gene GSTM1 and chronic kidney disease.